,
your personalized virtual assistant to find clinical trials. Go head, 
Jorge Garcia
Cleveland Clinic Taussig Cancer Institute, ...Cleveland, Ohio - 44195 (216-445-9567) |
- CLINICAL TRIALS 2
- CONDITIONS4
- INTERVENTIONS8
- SINCE2008
Sunitinib Malate in Treating Patients With Recurrent Transitional Cell Bladder Cancer
October 2008 - October 2012
Temsirolimus and Bevacizumab in Treating Patients With Hormone-Resistant Metastatic Prostate Cancer That Did Not Respond to Chemotherapy
January 2009 - January 2015
Prostatic Neoplasms
Urinary Bladder Neoplasms
Carcinoma
Carcinoma, Transitional Cell
Immunohistochemistry Staining Method
Laboratory Biomarker Analysis
Bevacizumab
Polymorphism Analysis
Temsirolimus
Sunitinib Malate
Tdt-Mediated Dutp Nick End Labeling Assay
Light Microscopy
